These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 21461713)
1. Do we still need human embryonic stem cells for stem cell-based therapies? Epistemic and ethical aspects. Hug K; Hermerén G Stem Cell Rev Rep; 2011 Nov; 7(4):761-74. PubMed ID: 21461713 [TBL] [Abstract][Full Text] [Related]
2. Ethical Aspects of Translating Research with Human Pluripotent Stem Cell Products into Clinical Practice: A Stakeholder Approach. Heyder C; Hansen SL; Wiesemann C New Bioeth; 2020 Mar; 26(1):3-16. PubMed ID: 32072871 [TBL] [Abstract][Full Text] [Related]
3. [The embryonic stem cells research. Example of biotechnology progress under extra-scientific pressure]. Gámez Escalona JA Cuad Bioet; 2013; 24(82):443-62. PubMed ID: 24483318 [TBL] [Abstract][Full Text] [Related]
7. Alternative sources of pluripotent stem cells: ethical and scientific issues revisited. Condic ML; Rao M Stem Cells Dev; 2010 Aug; 19(8):1121-9. PubMed ID: 20397928 [TBL] [Abstract][Full Text] [Related]
8. How to depolarise the ethical debate over human embryonic stem cell research (and other ethical debates too!). Espinoza N; Peterson M J Med Ethics; 2012 Aug; 38(8):496-500. PubMed ID: 22375081 [TBL] [Abstract][Full Text] [Related]
9. The procurement of cells for the derivation of human embryonic stem cell lines for therapeutic use: recommendations for good practice. Murdoch A; Braude P; Courtney A; Brison D; Hunt C; Lawford-Davies J; Moore H; Stacey G; Sethe S; ; Stem Cell Rev Rep; 2012 Mar; 8(1):91-9. PubMed ID: 21671059 [TBL] [Abstract][Full Text] [Related]
11. The ethics of stem cells revisited. de Miguel-Beriain I Adv Drug Deliv Rev; 2015 Mar; 82-83():176-80. PubMed ID: 25446134 [TBL] [Abstract][Full Text] [Related]
12. Differences in the microrheology of human embryonic stem cells and human induced pluripotent stem cells. Daniels BR; Hale CM; Khatau SB; Kusuma S; Dobrowsky TM; Gerecht S; Wirtz D Biophys J; 2010 Dec; 99(11):3563-70. PubMed ID: 21112280 [TBL] [Abstract][Full Text] [Related]
13. Human embryonic and induced pluripotent stem cell research trends: complementation and diversification of the field. Kobold S; Guhr A; Kurtz A; Löser P Stem Cell Reports; 2015 May; 4(5):914-25. PubMed ID: 25866160 [TBL] [Abstract][Full Text] [Related]
14. The decision on the "optimal" human pluripotent stem cell. Rosner M; Schipany K; Hengstschläger M Stem Cells Transl Med; 2014 May; 3(5):553-9. PubMed ID: 24692589 [TBL] [Abstract][Full Text] [Related]
15. Q&A: Stemming the tide of misinformation. Interview by Michael Eisenstein. Shevde N Nature; 2012 Feb; 483(7387):S27. PubMed ID: 22378126 [No Abstract] [Full Text] [Related]
16. Law, ethics, religion, and clinical translation in the 21st century. Trounson A Stem Cells; 2010 Jan; 28(1):2. PubMed ID: 19998372 [No Abstract] [Full Text] [Related]
18. Ethical issues in stem cell research and therapy. King NM; Perrin J Stem Cell Res Ther; 2014 Jul; 5(4):85. PubMed ID: 25157428 [TBL] [Abstract][Full Text] [Related]
19. Generation of red blood cells from human embryonic/induced pluripotent stem cells for blood transfusion. Ebihara Y; Ma F; Tsuji K Int J Hematol; 2012 Jun; 95(6):610-6. PubMed ID: 22648827 [TBL] [Abstract][Full Text] [Related]
20. Human embryonic stem cell therapies for neurodegenerative diseases. Tomaskovic-Crook E; Crook JM CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):440-8. PubMed ID: 21495960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]